Get started
Author

Michael Austin Brooks

Observed names: M. Brooks, M.A. Brooks, Michael A Brooks, Michael A. Brooks, Michael Brooks
Observed institutions: Houston Methodist, Michael E. DeBakey VA Medical Center, Cleveland Clinic, Baylor College of Medicine, Ben Taub Hospital, Dan L Duncan Comprehensive Cancer Center
ORCID: 0000-0001-9887-9380
Observed ORCID: 0000-0001-9887-9380
OpenAlex ID: A5020249653
Positive association of collagen type I with non-muscle invasive bladder cancer progression
2016 · Michael Brooks, Qianxing Mo, et al. · Oncotarget · 77
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality
2021 · Michael A. Brooks, Lewis Thomas, et al. · JCO Precision Oncology · 29
External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy
2015 · Michael Brooks, Guilherme Godoy, et al. · The Journal of Urology · 20
Outcomes of prostatic urethral lift in a medically complex population at a veterans affairs hospital
2021 · Kelly Lehner, Shreeya Popat, et al. · BJUI Compass · 13
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
2023 · Carlos Riveros, Sanjana Ranganathan, et al. · Urologic Oncology Seminars and Original Investigations · 12
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy
2021 · Michael A. Brooks, Lewis Thomas, et al. · Urologic Oncology Seminars and Original Investigations · 10
PDF
The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis
2019 · Lewis J. Thomas, Michael A. Brooks, et al. · Urologic Clinics of North America · 7
Real-world experience on tolerability and safety of relugolix combined with androgen signaling inhibitors in patients with advanced prostate cancer.
2024 · Jian Guan, Shubham Adroja, et al. · Journal of Clinical Oncology · 5
PDF
Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database
2023 · Kelvin Lim, Carlos Riveros, et al. · Urologic Oncology Seminars and Original Investigations · 3
Genomic landscape of advanced prostate cancer in racial minority populations: Real-world experience in a safety-net hospital oncology clinic.
2021 · Tamer Khashab, Alexander D Le, et al. · Journal of Clinical Oncology · 3
Prevalence of microsatellite instability and monitoring response to immune checkpoint inhibition utilizing liquid biopsy among African American men with advanced prostate cancer.
2021 · Tamer Khashab, Alexander D Le, et al. · Journal of Clinical Oncology · 2
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible muscle invasive bladder cancer (RAD VACCINE MIBC).
2022 · Raj Satkunasivam, Kelvin Lim, et al. · Journal of Clinical Oncology · 1
Adverse pathology as a predictor of distant metastasis and prostate cancer mortality with 20-year follow up.
2021 · Michael Austin Brooks, Lewis Thomas, et al. · Journal of Clinical Oncology · 1
Disease Detection Rate of Combination Ga-68 PSMA-PET/CT and Whole-Body MRI in Biochemical Recurrence After Prostatectomy
2025 · Sajeev Sridhar, Pankaj Patel, et al. · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
V03-09 Single Port Robotic Transvesical Simple Prostatectomy - Dock Stacking Technique
2025 · Zachary B. Kahlenberg, Carlos Riveros, et al. · The Journal of Urology
Mp28-14 Real-world Survival Outcomes Associated With Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Papillary Renal Cell Carcinoma
2023 · Carlos Riveros, Sanjana Ranganathan, et al. · The Journal of Urology
Abstract 549: Genomic characterization and monitoring molecular response to treatment in African American (AA) advanced prostate cancer (PC) patients (pts) via next-generation sequencing (NGS): Real-world experience in a safety net hospital Oncology clinic
2021 · Tamer Khashab, Salma Kaochar, et al. · Cancer Research
Adverse pathology at radical prostatectomy, GPS™ test, and clinical/pathology features as predictors of long-term prostate cancer outcomes
2020 · M.A. Brooks, L.J. Thomas, et al. · European Urology Open Science
Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making.
2019 · Michael Austin Brooks, Anita Misra-Hebert, et al. · Journal of Clinical Oncology
Mp46-02 Prostate Cancer Screening Nomogram Predicting 15-year Risk of Clinically Significant Prostate Cancer, Developed Using Competing Risk Analysis
2018 · Michael Brooks, Sigrid Carlsson, et al. · The Journal of Urology
Mp46-01 Development of Prostate Cancer Screening Nomograms for Predicting 15-year Risk of Prostate Cancer Diagnosis and Prostate Cancer Mortality, With Other-cause Mortality as Competing Event
2018 · Sigrid Carlsson, Michael Brooks, et al. · The Journal of Urology
Development of prostate specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)
2018 · S. Carlsson, M. Brooks, et al. · European Urology Supplements
Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM).
2018 · Michael Austin Brooks, Sigrid V. Carlsson, et al. · Journal of Clinical Oncology
Works count: 23
Citation count: 183
H-index: 7
I10-index: 6
Year
Topic
Type